These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2093020)

  • 41. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis.
    Vantrappen G; Rutgeerts L; Schurmans P; Coenegrachts JL
    Dig Dis Sci; 1988 May; 33(5):523-9. PubMed ID: 3282846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical development programme for omeprazole.
    Walan A
    Digestion; 1990; 47 Suppl 1():54-8; discussion 76. PubMed ID: 2093016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE; Fraga P; Mack M; Sabesin SM; Bochenek W;
    Aliment Pharmacol Ther; 2004 Sep; 20(5):567-75. PubMed ID: 15339328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.
    Lind T; Cederberg C; Idström JP; Lönroth H; Olbe L; Lundell L
    Scand J Gastroenterol; 1991 Jun; 26(6):620-6. PubMed ID: 1862300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
    Klinkenberg-Knol EC; Meuwissen SG
    Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
    Collen MJ; Strong RM
    Dig Dis Sci; 1992 Jun; 37(6):897-903. PubMed ID: 1587194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of reflux oesophagitis with ranitidine.
    Wesdorp IC; Dekker W; Klinkenberg-Knol EC
    Gut; 1983 Oct; 24(10):921-4. PubMed ID: 6311693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Omeprazole versus ranitidine in erosive oesophagitis.
    Zeitoun P; Desjars De Keranroué N; Isal JP
    Lancet; 1987 Sep; 2(8559):621-2. PubMed ID: 2887900
    [No Abstract]   [Full Text] [Related]  

  • 50. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime.
    Halvorsen L; Lee FI; Wesdorp IC; Johnson NJ; Mills JG; Wood JR
    Aliment Pharmacol Ther; 1989 Apr; 3(2):171-81. PubMed ID: 2491468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Healing and relapse of severe peptic esophagitis after treatment with omeprazole.
    Hetzel DJ; Dent J; Reed WD; Narielvala FM; Mackinnon M; McCarthy JH; Mitchell B; Beveridge BR; Laurence BH; Gibson GG
    Gastroenterology; 1988 Oct; 95(4):903-12. PubMed ID: 3044912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.
    Brunner G; Creutzfeldt W; Harke U; Lamberts R
    Digestion; 1988; 39(2):80-90. PubMed ID: 3410170
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis.
    Ruth M; Enbom H; Lundell L; Lönroth H; Sandberg N; Sandmark S
    Scand J Gastroenterol; 1988 Nov; 23(9):1141-6. PubMed ID: 3073525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
    Bardhan KD; Cherian P; Jones RB; Vaishnavi A; Manek S; Bishop A; Polak J; Brooks A; Morris P; Thompson M; D'Silva J; Parkin S; Patterson J; Gillon KR
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):515-9. PubMed ID: 9513825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
    Dammann HG; Blum AL; Lux G; Rehner M; Riecken EO; Schiessel R; Wienbeck M; Witzel L; Berger J
    Dtsch Med Wochenschr; 1986 Jan; 111(4):123-8. PubMed ID: 3510847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study.
    Hine KR; Holmes GK; Melikian V; Lucey M; Fairclough PD
    Digestion; 1984; 29(2):119-23. PubMed ID: 6329862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study.
    Bovero E; Cheli R; Barbara L; Baldi F; Boero A; Mura GC; Camarri E; Corradini P; Dobrilla G; Piazzi L
    Hepatogastroenterology; 1987 Aug; 34(4):155-9. PubMed ID: 3311954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations.
    Bate CM; Keeling PW; O'Morain C; Wilkinson SP; Foster DN; Mountford RA; Temperley JM; Harvey RF; Thompson DG; Davis M
    Gut; 1990 Sep; 31(9):968-72. PubMed ID: 2210463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.